AGP Executive Report
Last update: 8 hours agoEbola Vaccine Push: DRC expanded Ebola vaccination in Ituri, with MSF and partners launching the BRAVO study in Bunia to vaccinate about 20,000 frontline workers and track whether Ervebo helps against the Bundibugyo strain; Ebola Reality Check: WHO reported uneven progress—cases falling in Ituri and Haut Uele but rising sharply in North Kivu—plus many infections detected only after people die in the community; Mpox Lab Accuracy: Swiss-led research in The Lancet Infectious Diseases found nearly 35% of mpox PCR positives in several Congolese cities may reflect contaminated samples, raising the risk of false diagnoses; AI in Health and Research: NanoViricides began Phase II enrollment in DRC for NV-387 mpox treatment using oral gummies; AI for Minerals: KoBold Metals is using AI-guided exploration in the DRC to find critical minerals and reduce reliance on China’s dominance in copper and cobalt; Digital Payments: Visa named Fally Ipupa as brand ambassador for Visa Pay in DRC, aiming to boost cashless payments; Conflict and Rights: Amnesty says M23 fighters and Rwandan authorities abused miners and trafficked gold and coltan, with violations potentially amounting to war crimes; Information Warfare: Anthropic reported misuse of Claude AI to generate pro-government DRC narratives via fake news networks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.